A Phase I Study of QL1604 for Advanced Solid Tumors

NCT05801094 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: QL1604

Sponsor

Qilu Pharmaceutical Co., Ltd.